MedTech Spectrum

Article Name Medtech

The FDA Is Phasing Out Animal Testing. Our Replacements Must Catch Up Fast.

In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead.

04th August, 2025

Advanced MedTech Drives Patient-Centred Innovation in Urology Across Asia

In conversation with MedTech Spectrum, Mr. Wong Yau Chung, Group CEO of Advanced MedTech Holdings, shares how the company is advancing kidney stone care, laser technologies, and digital platforms to address emerging urological challenges.

04th August, 2025

Vietnam Advances Paediatric Neurosurgery with Robotic SEEG Milestone at Vinmec

Dr. Truong Van Tri discusses Vietnam’s first robot-assisted SEEG procedure in a 9-year-old with drug-resistant epilepsy—highlighting precision innovation, local expertise, and a national vision for epilepsy care.

04th August, 2025

Olympus Supports American Lung Association’s New Lung Nodule Education Campaign Ahead of World Lung Cancer Day

Initiative aims to reduce anxiety and improve patient understanding after lung nodule detection, offering clear resources and guidance to support informed decisions and early intervention.

04th August, 2025

Demetra Launches Global Spine Division Following Strategic Acquisition of OrthoFundamentals

With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.

04th August, 2025

ELIXIR MD Expands into Australia and New Zealand with Exclusive Launch of Breakthrough Facial Surgery Device

In partnership with High Tech Medical Pty Ltd., ELIXIR MD brings its proprietary ELIXIR MD™ device and advanced perioperative protocols to one of the world’s fastest-growing aesthetic surgery markets, redefining post-operative care and patient recovery outcomes.

04th August, 2025

MiRus Secures NTAP Approval from CMS for Breakthrough EUROPA® Cervical Spine System

Awarded for its proprietary MoRe® alloy-based 2.9 mm rod, the EUROPA® PCF System offers a low-profile, high-strength solution for cervical and upper thoracic spine surgery—now eligible for Medicare reimbursement under the New Technology Add-on Payment programme.

04th August, 2025

MAGENTIQ EYE Secures Series A Funding to Accelerate Global Expansion of AI-Powered Colonoscopy Platform

Led by aMoon, the round fuels development of advanced GI diagnostics and supports global rollout of MAGENTIQ-COLO™, the FDA- and CE-cleared solution enhancing real-time polyp detection and analysis during colonoscopy procedures.

31st July, 2025

Galaxy Therapeutics Opens New 9,200 Sq. Ft. Facility to Support Global Scale-Up of Brain Aneurysm Solutions

Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies.

31st July, 2025

Alafair Biosciences Earns Dual FDA 510(k) Clearances for VersaCoat™ Flowable Hydrogel

VersaCoat, a syringe-deliverable soft-tissue protector, brings Alafair’s proven hyaluronic acid and alginate formula to complex surgical sites—expanding its impact in orthopedic, trauma, and sports medicine procedures.

31st July, 2025

RIVANNA Secures $9.92M BARDA Funding to Fast-Track AI-Powered Fracture Detection System

With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.

31st July, 2025

TrilliumBiO and T-NeuroDx Partner to Advance Blood-Based Diagnostics for Early Alzheimer’s Detection

Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease

30th July, 2025

Quasar Medical Establishes Global Headquarters in Singapore to Drive MedTech Innovation and Global Growth

Strategic relocation from Hong Kong strengthens ties to Asia’s thriving MedTech ecosystem, enhances collaboration with global partners, and supports ambitious expansion plans

30th July, 2025

Johnson & Johnson MedTech Launches VIRTUGUIDE™ System to Transform Bunion Surgery with AI Precision

AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes

30th July, 2025

MD Anderson and TOPPAN Forge Alliance to Advance invivoid™ 3D Organoid Technology for Personalized Cancer Therapy

Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types

30th July, 2025

How the FDA’s 510(k) Pathway and Risk-Based Oversight Are Shaping the Future of Medical Device Regulation

By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance

30th July, 2025